Research
-
Opioid Prescribing Decreases After Learning of a Patient’s Fatal Overdose
Results of the randomized trial show opioid prescribing decreases after a clinician learns of a patient’s fatal overdose.
Categorized in -
Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications
The researchers find Medicaid eligibility expansions are linked to increases in prescription fills for diabetes drugs.
Categorized in -
How Would Individual Market Premiums Change in 2019 in a Stable Policy Environment?
Matthew Fielder examines how premiums would change in 2019 absent recent policy changes that are set to take effect.
-
Are High-Deductible Plans a Healthy Option for Patients?
High-deductible health plans may have unintended consequences for patients.
Categorized in -
Stabilizing and Strengthening the Individual Health Insurance Market
Mark Hall examines the causes of instability in the individual market and identifies measures to help improve stability based off of interviews with key stakeholders in 10 states.
-
Growing Number of Unsubsidized Part D Beneficiaries with Catastrophic Spending Suggests Need for Out-Of-Pocket Cap
More than one million Part D enrollees who were not eligible for cost assistance reached the catastrophic coverage in 2015.
Categorized in -
Education and Psychosocial Functioning Among Older Adults: 4-Year Change in Sense of Control and Hopelessness
In this study, researchers found a cumulative advantage of higher levels of education for psychosocial functioning in older adults.
-
Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials
Drug innovation in the last decade increased productivity by 4.8 million work days, resulting in $221 billion in annual wages.
Categorized in -
Disentangling the Stress Process: Race Differences in the Experience of Chronic Stressors
Older blacks and US-born and foreign-born Hispanics report more chronic stress exposure than whites and are two to three times as likely to experience financial strain and housing-related stress.
-
Economics of the Pharmaceutical Industry
Darius Lakdawalla reviews the economics literature on the pharmaceutical industry, focusing particularly on its positive and normative implications for the innovation, pricing, and marketing decisions of pharmaceutical firms.
Categorized in